These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2415742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T, Kolitz J, Levi E, Polivka A, Oez S, Miller G, Welte K.
    Cancer Res; 1988 Feb 15; 48(4):891-8. PubMed ID: 3257413
    [Abstract] [Full Text] [Related]

  • 7. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
    Wright SC, Weitzen ML, Kahle R, Granger GA, Bonavida B.
    J Immunol; 1983 May 15; 130(5):2479-83. PubMed ID: 6833762
    [Abstract] [Full Text] [Related]

  • 8. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS, Bramhall J, Bonavida B.
    J Immunol; 1986 Sep 15; 137(6):1977-84. PubMed ID: 2427588
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B, Katz J, Gottlieb M.
    J Immunol; 1986 Aug 15; 137(4):1157-63. PubMed ID: 3488345
    [Abstract] [Full Text] [Related]

  • 11. Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease.
    Kadish AS, Doyle AT, Steinhauer EH, Ghossein NA.
    J Immunol; 1981 Nov 15; 127(5):1817-22. PubMed ID: 6170674
    [Abstract] [Full Text] [Related]

  • 12. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC, Bonavida B.
    J Immunol; 1987 Mar 15; 138(6):1791-8. PubMed ID: 3493288
    [Abstract] [Full Text] [Related]

  • 13. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC, Bonavida B.
    J Immunol; 1984 Dec 15; 133(6):3415-23. PubMed ID: 6491292
    [Abstract] [Full Text] [Related]

  • 14. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
    Pedersen BK, Oxholm P.
    Clin Exp Immunol; 1988 May 15; 72(2):299-302. PubMed ID: 3409548
    [Abstract] [Full Text] [Related]

  • 15. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A, Vánky F, Klein E.
    J Natl Cancer Inst; 1985 Nov 15; 75(5):849-57. PubMed ID: 2414505
    [Abstract] [Full Text] [Related]

  • 16. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E, Targan SR.
    J Immunol; 1983 Mar 15; 130(3):1252-6. PubMed ID: 6822733
    [Abstract] [Full Text] [Related]

  • 17. [Interferon production and natural killer activity of peripheral blood lymphocytes obtained from patients with multiple sclerosis].
    Maruo Y.
    Hokkaido Igaku Zasshi; 1988 Jul 15; 63(4):521-33. PubMed ID: 2464533
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.